Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Solon Eiendom ASA : Disclosure of voting proxies received in connection with the AGM

Solon Eiendom ASA
Posted on: 19 May 17

Oslo, 19 May 2017: Solon Eiendom ASA (OSE: SOLON).
Simen Thorsen has as chairman of the board of directors of Solon received proxies to vote at the annual general meeting on 23 May 2017 (the " AGM "), for 16 384 616 shares, representing approx. 33,72 % of the total share capital and votes of the company. The proxies received are only valid for the AGM and will lapse automatically thereafter.

In addition, Simen Thorsen, through Hortulan AS, holds 12,894,090 shares, equalling 26.53% of the total share capital and votes of the company.

Together with the received proxies, Simen Thorsen may vote for 29,278,706 shares, representing approx. 60,2 % of the total share capital and votes of the company.

For further information, please contact:

Andreas Martinussen
Chief Executive Officer, Solon Eiendom ASA
E-mail: Cell Phone: +47 400 00 405

Scott Danielsen
Chief Financial Officer, Solon Eiendom ASA
E-mail: Cell Phone: +47 952 55 620

About Solon Eiendom ASA
Solon Eiendom is a Norwegian residential real estate development company focusing on the Oslo and Akershus region. Solon Eiendom was established in 2006 by founder Simen Thorsen and investor Tore Aksel Voldberg.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Solon Eiendom ASA via GlobeNewswire

Last updated on: 20/05/2017

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.